We've found
1,478
archived clinical trials in
Smoking Cessation
We've found
1,478
archived clinical trials in
Smoking Cessation
Bupropion in Helping Adults Stop Smoking
Updated: 8/27/2015
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated: 8/27/2015
Bupropion in Helping Adults Stop Smoking
Updated: 8/27/2015
A Phase II Study of the Effects of Extended Pre-Cessation Bupropion for Smoking Cessation
Status: Enrolling
Updated: 8/27/2015
Click here to add this to my saved trials

Enhanced Smoking Cessation Intervention for Smokers Exposed to the World Trade Center (WTC) Disaster
Updated: 9/1/2015
Enhanced Smoking Cessation Intervention for Smokers Exposed to the WTC Disaster
Status: Enrolling
Updated: 9/1/2015
Enhanced Smoking Cessation Intervention for Smokers Exposed to the World Trade Center (WTC) Disaster
Updated: 9/1/2015
Enhanced Smoking Cessation Intervention for Smokers Exposed to the WTC Disaster
Status: Enrolling
Updated: 9/1/2015
Click here to add this to my saved trials

Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD
Updated: 9/15/2015
Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD
Status: Enrolling
Updated: 9/15/2015
Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD
Updated: 9/15/2015
Use of Technological Advances to Prevent Smoking Relapse Among Smokers With PTSD
Status: Enrolling
Updated: 9/15/2015
Click here to add this to my saved trials

A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence
Updated: 9/18/2015
Proof-of-Concept Study of EVP-6124, an Alpha-7 Nicotinic Acetylcholine Receptor Agonist, Versus Placebo in Subjects With Nicotine Dependence
Status: Enrolling
Updated: 9/18/2015
A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence
Updated: 9/18/2015
Proof-of-Concept Study of EVP-6124, an Alpha-7 Nicotinic Acetylcholine Receptor Agonist, Versus Placebo in Subjects With Nicotine Dependence
Status: Enrolling
Updated: 9/18/2015
Click here to add this to my saved trials

Determinants of Smoking Cessation Among Latinos
Updated: 9/24/2015
Determinants of Smoking Cessation Among Latinos
Status: Enrolling
Updated: 9/24/2015
Determinants of Smoking Cessation Among Latinos
Updated: 9/24/2015
Determinants of Smoking Cessation Among Latinos
Status: Enrolling
Updated: 9/24/2015
Click here to add this to my saved trials

Acute Effects of Exercise in Smokers With Schizophrenia
Updated: 9/25/2015
Acute Effects of Exercise in Smokers With Schizophrenia
Status: Enrolling
Updated: 9/25/2015
Acute Effects of Exercise in Smokers With Schizophrenia
Updated: 9/25/2015
Acute Effects of Exercise in Smokers With Schizophrenia
Status: Enrolling
Updated: 9/25/2015
Click here to add this to my saved trials

Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority Smokers
Updated: 9/26/2015
Nicotine Replacement Therapy Methods for Pregnant Women
Status: Enrolling
Updated: 9/26/2015
Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority Smokers
Updated: 9/26/2015
Nicotine Replacement Therapy Methods for Pregnant Women
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials

Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority Smokers
Updated: 9/26/2015
Nicotine Replacement Therapy Methods for Pregnant Women
Status: Enrolling
Updated: 9/26/2015
Effectiveness of Nicotine Replacement Therapy in Reducing the Risk of Nicotine Exposure in Pregnant Minority Smokers
Updated: 9/26/2015
Nicotine Replacement Therapy Methods for Pregnant Women
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials

HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
Updated: 9/26/2015
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, MD: A Pilot Study of Biomarkers
Status: Enrolling
Updated: 9/26/2015
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
Updated: 9/26/2015
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, MD: A Pilot Study of Biomarkers
Status: Enrolling
Updated: 9/26/2015
Click here to add this to my saved trials

Trial on the Effectiveness of Mindfulness Training for Smokers
Updated: 9/30/2015
Phase 2 Randomized Trial on the Effectiveness of Mindfulness Training for Smokers, a Novel Intervention Designed to Help Smokers Quit Smoking
Status: Enrolling
Updated: 9/30/2015
Trial on the Effectiveness of Mindfulness Training for Smokers
Updated: 9/30/2015
Phase 2 Randomized Trial on the Effectiveness of Mindfulness Training for Smokers, a Novel Intervention Designed to Help Smokers Quit Smoking
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin School of Medicine and Public Health Center for Tobacco Research and Intervention

Click here to add this to my saved trials

Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Updated: 9/30/2015
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Status: Enrolling
Updated: 9/30/2015
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Updated: 9/30/2015
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Status: Enrolling
Updated: 9/30/2015
Click here to add this to my saved trials

Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Updated: 9/30/2015
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Status: Enrolling
Updated: 9/30/2015
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Updated: 9/30/2015
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
Status: Enrolling
Updated: 9/30/2015
Click here to add this to my saved trials

A Study to Examine Health Behavior Change Strategies for Primary Care
Updated: 9/30/2015
Common Measures, Better Outcomes (COMBO)
Status: Enrolling
Updated: 9/30/2015
A Study to Examine Health Behavior Change Strategies for Primary Care
Updated: 9/30/2015
Common Measures, Better Outcomes (COMBO)
Status: Enrolling
Updated: 9/30/2015
Click here to add this to my saved trials

Meriter Mindfulness Training for Smokers Program and Study
Updated: 9/30/2015
Meriter Mindfulness Training for Smokers Program and Study
Status: Enrolling
Updated: 9/30/2015
Meriter Mindfulness Training for Smokers Program and Study
Updated: 9/30/2015
Meriter Mindfulness Training for Smokers Program and Study
Status: Enrolling
Updated: 9/30/2015
Click here to add this to my saved trials

Extinction Updating in Reconsolidation
Updated: 10/1/2015
Reducing Smoking Cue Reactivity and Behavior Via Retrieval-Extinction Mechanism
Status: Enrolling
Updated: 10/1/2015
Extinction Updating in Reconsolidation
Updated: 10/1/2015
Reducing Smoking Cue Reactivity and Behavior Via Retrieval-Extinction Mechanism
Status: Enrolling
Updated: 10/1/2015
Click here to add this to my saved trials

Cognitive Training for Nicotine Dependence
Updated: 10/2/2015
Cognitive Training for Nicotine Dependence
Status: Enrolling
Updated: 10/2/2015
Cognitive Training for Nicotine Dependence
Updated: 10/2/2015
Cognitive Training for Nicotine Dependence
Status: Enrolling
Updated: 10/2/2015
Click here to add this to my saved trials

Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
Updated: 10/5/2015
Incentives Plus Bupropion for Smoking in Schizophrenics
Status: Enrolling
Updated: 10/5/2015
Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia
Updated: 10/5/2015
Incentives Plus Bupropion for Smoking in Schizophrenics
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials

Baclofen Effects on Smoking Urge and Withdrawal
Updated: 10/5/2015
Baclofen Effects on Smoking Urge and Withdrawal
Status: Enrolling
Updated: 10/5/2015
Baclofen Effects on Smoking Urge and Withdrawal
Updated: 10/5/2015
Baclofen Effects on Smoking Urge and Withdrawal
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Updated: 10/6/2015
Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings
Status: Enrolling
Updated: 10/6/2015
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Updated: 10/6/2015
Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings
Status: Enrolling
Updated: 10/6/2015
Click here to add this to my saved trials

SPECT Imaging of DAT Genotype
Updated: 10/7/2015
Use of SPECT (Single-photon Emission Computed Tomography) to Examine the Role of DAT (Dopamine Transporter) Genotype in Motivated Smoking Behavior
Status: Enrolling
Updated: 10/7/2015
SPECT Imaging of DAT Genotype
Updated: 10/7/2015
Use of SPECT (Single-photon Emission Computed Tomography) to Examine the Role of DAT (Dopamine Transporter) Genotype in Motivated Smoking Behavior
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials

Virtual Clinician Research Tool
Updated: 10/8/2015
Creating a Virtual Clinician Research Tool
Status: Enrolling
Updated: 10/8/2015
Virtual Clinician Research Tool
Updated: 10/8/2015
Creating a Virtual Clinician Research Tool
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials

Smoking Cessation Intervention: Effectiveness in Primary Care
Updated: 10/9/2015
Tobacco Dependence: Treatment and Outcomes; Pharmacotherapies: Effectiveness in Primary Care
Status: Enrolling
Updated: 10/9/2015
Smoking Cessation Intervention: Effectiveness in Primary Care
Updated: 10/9/2015
Tobacco Dependence: Treatment and Outcomes; Pharmacotherapies: Effectiveness in Primary Care
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials

Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources
Updated: 10/9/2015
Evaluation of NCI Smoking Intervention Resources
Status: Enrolling
Updated: 10/9/2015
Evaluation of National Cancer Institute (NCI) Smoking Intervention Resources
Updated: 10/9/2015
Evaluation of NCI Smoking Intervention Resources
Status: Enrolling
Updated: 10/9/2015
University of Wisconsin Center for Tobacco Research and Intervention, School of Medicine and Public Health

Click here to add this to my saved trials

Mindfulness Training for Smokers Online Feasibility Study
Updated: 10/9/2015
Mindfulness Training for Smokers Online Feasibility Study
Status: Enrolling
Updated: 10/9/2015
Mindfulness Training for Smokers Online Feasibility Study
Updated: 10/9/2015
Mindfulness Training for Smokers Online Feasibility Study
Status: Enrolling
Updated: 10/9/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Updated: 10/12/2015
A Phase 4, Randomized, Double-blind, Active And Placebo-controlled, Multicenter Study Evaluating The Neuropsychiatric Safety And Efficacy Of 12 Weeks Varenicline Tartrate 1mg Bid And Bupropion Hydrochloride 150mg Bid For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders
Status: Enrolling
Updated: 10/12/2015
Click here to add this to my saved trials
